.

Idera Pharmaceuticals reported $0 in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agenus AGEN:US $ 13.7M 0.48M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 36522M 332M
Biogen BIIB:US $ 7277.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Cytrx CYTR:US 0 0
Dynavax Technologies DVAX:US $ 221.03M 0.27M
Eli Lilly And LLY:US $ 16813.8M 305M
GlaxoSmithKline GSK:LN 2211100M 1121700M
Mirati Therapeutics MRTX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M